These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37966414)

  • 1. Discussion to: To decline or not to decline: Consequences of decision-making regarding lung offers from donors with hepatitis C.
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1977-1978. PubMed ID: 37966414
    [No Abstract]   [Full Text] [Related]  

  • 2. To decline or not to decline: Consequences of decision-making regarding lung offers from donors with hepatitis C.
    Ruck JM; Bowring MG; Durand CM; Ha JS; Massie AB; Segev DL; Merlo CA; Bush EL
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1967-1976.e2. PubMed ID: 37678605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-lung transplants: the fate of the second donor lung.
    Olland A; Falcoz PE; Santelmo N; Massard G
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):987-9. PubMed ID: 23849893
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of US Public Health Service increased risk deceased donor designation on organ utilization.
    Sapiano MRP; Jones JM; Bowman J; Levi ME; Basavaraju SV
    Am J Transplant; 2019 Sep; 19(9):2560-2569. PubMed ID: 30959569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the supply of donor organs: being careful with the gift of life.
    Roberts MS
    JAMA; 2010 Dec; 304(23):2643-4. PubMed ID: 21156954
    [No Abstract]   [Full Text] [Related]  

  • 6. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
    Mooney JJ; Purington N; Mohabir P; Dhillon GS
    Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung transplantation is hampered by the organ shortage].
    Lindstedt S; Riise LG; Gilljam M; Wierup P; Gustafsson R; Koul BL; Ingemansson R
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1747-9. PubMed ID: 23097882
    [No Abstract]   [Full Text] [Related]  

  • 9. Availability of transplantable organs from brain stem dead donors in intensive care units.
    Gore SM; Taylor RM; Wallwork J
    BMJ; 1991 Jan; 302(6769):149-53. PubMed ID: 1995135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the rational use of HCV+ organs worldwide.
    Morales JM; Sawinski D
    Clin Transplant; 2019 Dec; 33(12):e13739. PubMed ID: 31648391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timely referral of potential organ donors.
    Ehrle R
    Crit Care Nurse; 2006 Apr; 26(2):88-93. PubMed ID: 16565283
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiological Analysis of Unused Donor Lungs: A Tool to Improve Donor Acceptance for Transplantation?
    Verleden SE; Martens A; Ordies S; Heigl T; Bellon H; Vandermeulen E; Van Herck A; Sacreas A; Verschakelen J; Coudyzer W; Van Raemdonck DE; Vos R; Weynand B; Verleden GM; Vanaudenaerde B; Neyrinck A
    Am J Transplant; 2017 Jul; 17(7):1912-1921. PubMed ID: 28251829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A kidney offer acceptance decision tool to inform the decision to accept an offer or wait for a better kidney.
    Wey A; Salkowski N; Kremers WK; Schaffhausen CR; Kasiske BL; Israni AK; Snyder JJ
    Am J Transplant; 2018 Apr; 18(4):897-906. PubMed ID: 28925596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing organ donation opportunities through donation after cardiac death.
    Edwards J; Mulvania P; Robertson V; George G; Hasz R; Nathan H; D'Alessandro A
    Crit Care Nurse; 2006 Apr; 26(2):101-15. PubMed ID: 16565285
    [No Abstract]   [Full Text] [Related]  

  • 15. Current Use of Hearts From Hepatitis C Viremic Donors.
    Moayedi Y; Fan CPS; Gulamhusein AF; Manlhiot C; Ross HJ; Teuteberg JJ; Khush KK
    Circ Heart Fail; 2018 Dec; 11(12):e005276. PubMed ID: 30562093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hard-to-place kidney offers: Donor- and system-level predictors of discard.
    Narvaez JRF; Nie J; Noyes K; Leeman M; Kayler LK
    Am J Transplant; 2018 Nov; 18(11):2708-2718. PubMed ID: 29498197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in donor organ offer acceptance and lung transplantation survival.
    Mulvihill MS; Lee HJ; Weber J; Choi AY; Cox ML; Yerokun BA; Bishawi MA; Klapper J; Kuchibhatla M; Hartwig MG
    J Heart Lung Transplant; 2020 Apr; 39(4):353-362. PubMed ID: 32029400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Pruett TL; Clark MA; Taranto SE
    Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appraisal of hepatitis C viremic donors: how far could we expand the heart donor pool?
    Suarez-Pierre A; Lui C; Zhou X; Morales LF; Choi CW
    J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):572-574. PubMed ID: 31157661
    [No Abstract]   [Full Text] [Related]  

  • 20. Does donor arterial partial pressure of oxygen affect outcomes after lung transplantation? A review of more than 12,000 lung transplants.
    Zafar F; Khan MS; Heinle JS; Adachi I; McKenzie ED; Schecter MG; Mallory GB; Morales DL
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):919-25. PubMed ID: 22341426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.